138 related articles for article (PubMed ID: 10701153)
1. Infliximab for fistulas: a hole in one?
Korzenik JR
Inflamm Bowel Dis; 2000 Feb; 6(1):62-3. PubMed ID: 10701153
[No Abstract] [Full Text] [Related]
2. Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE; Anderson FH; Bernstein CN; Chey WY; Feagan BG; Fedorak RN; Kamm MA; Korzenik JR; Lashner BA; Onken JE; Rachmilewitz D; Rutgeerts P; Wild G; Wolf DC; Marsters PA; Travers SB; Blank MA; van Deventer SJ
N Engl J Med; 2004 Feb; 350(9):876-85. PubMed ID: 14985485
[TBL] [Abstract][Full Text] [Related]
3. Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease.
Vaughan D; Drumm B
N Engl J Med; 1999 Jan; 340(3):239-40. PubMed ID: 9917236
[No Abstract] [Full Text] [Related]
4. Infliximab for the treatment of fistulas in patients with Crohn's disease.
Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ
N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190
[TBL] [Abstract][Full Text] [Related]
5. Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.
de Ridder L; Escher JC; Bouquet J; Schweizer JJ; Rings EH; Tolboom JJ; Houwen RH; Norbruis OF; Derkx BH; Taminiau JA
J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):46-52. PubMed ID: 15187780
[TBL] [Abstract][Full Text] [Related]
6. Infliximab: lack of efficacy on perforating complications in Crohn's disease.
Miehsler W; Reinisch W; Kazemi-Shirazi L; Dejaco C; Novacek G; Ferenci P; Herbst F; Karner J; Téleky B; Schober E; Vogelsang H
Inflamm Bowel Dis; 2004 Jan; 10(1):36-40. PubMed ID: 15058525
[TBL] [Abstract][Full Text] [Related]
7. Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Paré P
Can J Gastroenterol; 2001 Nov; 15(11):751-6. PubMed ID: 11727005
[TBL] [Abstract][Full Text] [Related]
8. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease.
Parsi MA; Lashner BA; Achkar JP; Connor JT; Brzezinski A
Am J Gastroenterol; 2004 Mar; 99(3):445-9. PubMed ID: 15056083
[TBL] [Abstract][Full Text] [Related]
9. Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease.
Fries W; La Malfa G; Costantino G; Repici A; Mazziotti S; Navarra G
Inflamm Bowel Dis; 2011 Feb; 17(2):671-3. PubMed ID: 20848472
[No Abstract] [Full Text] [Related]
10. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging.
Bell SJ; Halligan S; Windsor AC; Williams AB; Wiesel P; Kamm MA
Aliment Pharmacol Ther; 2003 Feb; 17(3):387-93. PubMed ID: 12562451
[TBL] [Abstract][Full Text] [Related]
11. Infliximab in pediatric Crohn disease patients with enterovesicular fistulas.
Teitelbaum JE; Saeed S; Triantafyllopoulou M; Daum F
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):279-82. PubMed ID: 17255846
[No Abstract] [Full Text] [Related]
12. [Surgery -- fistulas].
Buhr HJ; Kroesen AJ; Stange EF;
Z Gastroenterol; 2003 Jan; 41(1):43-9. PubMed ID: 12541173
[No Abstract] [Full Text] [Related]
13. [Treatment with chimeric monoclonal antitumor necrosis factor (infliximab) of patients with active steroid-dependent/resistant Crohn's disease and fistulas].
Martorana G; Casà A; Oliva L; Orlando A; Cottone M
Recenti Prog Med; 2001; 92(7-8):451-5. PubMed ID: 11475786
[TBL] [Abstract][Full Text] [Related]
14. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
15. Treatment of fistulas in Crohn's disease with infliximab.
Löfberg R
Gut; 1999 Nov; 45(5):642-3. PubMed ID: 10517896
[No Abstract] [Full Text] [Related]
16. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
17. Octreotide for enterocutaneous fistulas of Crohn's disease.
Lavy A; Yasin K
Can J Gastroenterol; 2003 Sep; 17(9):555-8. PubMed ID: 14532930
[TBL] [Abstract][Full Text] [Related]
18. Closure of jejuno-colic fistula in Crohn's disease with infliximab.
Sood A; Midha V; Sood N
Indian J Gastroenterol; 2001; 20(4):164-5. PubMed ID: 11497186
[No Abstract] [Full Text] [Related]
19. Guidelines for treatment with infliximab for Crohn's disease.
Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
[TBL] [Abstract][Full Text] [Related]
20. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety?
Fiocchi C
N Engl J Med; 2004 Feb; 350(9):934-6. PubMed ID: 14985492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
